{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T05:17:19Z","timestamp":1765603039525,"version":"3.48.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004028","name":"Jiangnan University","doi-asserted-by":"publisher","award":["2022ZHZD02"],"award-info":[{"award-number":["2022ZHZD02"]}],"id":[{"id":"10.13039\/501100004028","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejmech.2025.117724","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T18:59:39Z","timestamp":1747162779000},"page":"117724","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design, synthesis, and biological evaluation of TRPV4-KCa2.3 coupling enhancers as novel therapeutic agents for hypertension"],"prefix":"10.1016","volume":"294","author":[{"given":"Shaying","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huabing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junlan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunlei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejmech.2025.117724_bib1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41569-024-01062-6","article-title":"Reactive oxygen species in hypertension","volume":"22","author":"Camargo","year":"2025","journal-title":"Nat. Rev. Cardiol."},{"issue":"9587","key":"10.1016\/j.ejmech.2025.117724_bib2","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(07)61299-9","article-title":"Essential hypertension","volume":"370","author":"Messerli","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117724_bib3","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/HYPERTENSIONAHA.116.07292","article-title":"Identification of serum metabolites associated with incident hypertension in the European prospective investigation into cancer and nutrition-potsdam study","volume":"68","author":"Dietrich","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.ejmech.2025.117724_bib4","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117724_bib5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/cvr\/cvac130","article-title":"Addressing global disparities in blood pressure control: perspectives of the international society of hypertension","volume":"119","author":"Schutte","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejmech.2025.117724_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102344","article-title":"Hypertension in an ageing population: diagnosis, mechanisms, collateral health risks, treatments, and clinical challenges","volume":"98","author":"Kim","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ejmech.2025.117724_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.14","article-title":"Hypertension","volume":"4","author":"Oparil","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"7","key":"10.1016\/j.ejmech.2025.117724_bib8","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1161\/CIRCRESAHA.118.313236","article-title":"Hypertension management in older and frail older patients","volume":"124","author":"Benetos","year":"2019","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.ejmech.2025.117724_bib9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2215\/CJN.05280419","article-title":"CJASN and disclosure of conflicts of interest","volume":"14","author":"Mehrotra","year":"2019","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117724_bib10","doi-asserted-by":"crossref","first-page":"524","DOI":"10.2215\/CJN.06180616","article-title":"Recognition and management of resistant hypertension","volume":"12","author":"Braam","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117724_bib11","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/j.2040-4603.2012.tb00402.x","article-title":"Structure and composition of pulmonary arteries, capillaries, and veins","volume":"2","author":"Townsley","year":"2012","journal-title":"Compr. Physiol."},{"issue":"13","key":"10.1016\/j.ejmech.2025.117724_bib12","first-page":"2589","article-title":"Therapeutic targeting of inflammation in hypertension: from novel mechanisms to translational perspective","volume":"117","author":"Murray","year":"2021","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.ejmech.2025.117724_bib13","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1681\/ASN.0000000000000315","article-title":"Resistant hypertension in dialysis: epidemiology, diagnosis, and management","volume":"35","author":"Georgianos","year":"2024","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejmech.2025.117724_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-079108","article-title":"Diagnosis and management of resistant hypertension","volume":"385","author":"Schiffrin","year":"2024","journal-title":"Bmj"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117724_bib15","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1161\/HYPERTENSIONAHA.110.163576","article-title":"Inflammation, immunity, and hypertension","volume":"57","author":"Harrison","year":"2011","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.ejmech.2025.117724_bib16","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa2213169","article-title":"Phase 2 trial of baxdrostat for treatment-resistant hypertension","volume":"388","author":"Freeman","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.ejmech.2025.117724_bib17","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.bbadis.2007.02.013","article-title":"TRP channels in endothelial function and dysfunction","volume":"1772","author":"Kwan","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.ejmech.2025.117724_bib18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41569-022-00739-0","article-title":"Mechanisms and consequences of endothelial cell senescence","volume":"20","author":"Bloom","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"issue":"3","key":"10.1016\/j.ejmech.2025.117724_bib19","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1161\/CIRCRESAHA.122.322332","article-title":"Integrin-dependent cell-matrix adhesion in endothelial health and disease","volume":"132","author":"Aman","year":"2023","journal-title":"Circ. Res."},{"issue":"37","key":"10.1016\/j.ejmech.2025.117724_bib20","doi-asserted-by":"crossref","first-page":"33704","DOI":"10.1074\/jbc.M204828200","article-title":"Molecular determinants of permeation through the cation channel TRPV4","volume":"277","author":"Voets","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2025.117724_bib21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1254\/jphs.08133FP","article-title":"TRPV4-like non-selective cation currents in cultured aortic myocytes","volume":"108","author":"Tanaka","year":"2008","journal-title":"J. Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.ejmech.2025.117724_bib22","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1002\/j.2040-4603.2024.tb00295.x","article-title":"A TRP to pathological angiogenesis and vascular normalization","volume":"14","author":"Katari","year":"2024","journal-title":"Compr. Physiol."},{"issue":"159","key":"10.1016\/j.ejmech.2025.117724_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004276","article-title":"An orally active TRPV4 channel blocker prevents and resolves pulmonary edema induced by heart failure","volume":"4","author":"Thorneloe","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.1016\/j.ejmech.2025.117724_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/md18100519","article-title":"Design, synthesis and in vitro experimental validation of novel TRPV4 antagonists inspired by labdane diterpenes","volume":"18","author":"Mazzotta","year":"2020","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ejmech.2025.117724_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pharmthera.2017.02.019","article-title":"Modulation of the TRPV4 ion channel as a therapeutic target for disease","volume":"177","author":"Grace","year":"2017","journal-title":"Pharmacol. Ther."},{"issue":"16","key":"10.1016\/j.ejmech.2025.117724_bib26","doi-asserted-by":"crossref","first-page":"13569","DOI":"10.1074\/jbc.M200062200","article-title":"Activation of TRPV4 channels (hVRL-2\/mTRP12) by phorbol derivatives","volume":"277","author":"Watanabe","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.117724_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2021.105983","article-title":"Endothelial signaling at the core of neurovascular coupling: the emerging role of endothelial inward-rectifier K(+) (K(ir)2.1) channels and N-methyl-d-aspartate receptors in the regulation of cerebral blood flow","volume":"135","author":"Negri","year":"2021","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"5","key":"10.1016\/j.ejmech.2025.117724_bib28","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1159\/000074549","article-title":"Myoendothelial gap junctions May provide the pathway for EDHF in mouse mesenteric artery","volume":"40","author":"Dora","year":"2003","journal-title":"J. Vasc. Res."},{"issue":"Pt A","key":"10.1016\/j.ejmech.2025.117724_bib29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.phrs.2016.08.003","article-title":"The paracrine control of vascular motion. A historical perspective","volume":"113","author":"Nava","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.ejmech.2025.117724_bib30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.biopsych.2013.04.026","article-title":"Increased small conductance calcium-activated potassium type 2 channel-mediated negative feedback on N-methyl-D-aspartate receptors impairs synaptic plasticity following context-dependent sensitization to morphine","volume":"75","author":"Fakira","year":"2014","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.ejmech.2025.117724_bib31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1124\/mol.108.051425","article-title":"Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure","volume":"75","author":"Sankaranarayanan","year":"2009","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117724_bib32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1748-1716.2010.02240.x","article-title":"Improvement of endothelium-dependent vasodilations by SKA-31 and SKA-20, activators of small- and intermediate-conductance Ca2+ -activated K+ -channels","volume":"203","author":"Hasenau","year":"2011","journal-title":"Acta Physiol."},{"issue":"4","key":"10.1016\/j.ejmech.2025.117724_bib33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11906-010-0118-2","article-title":"Endothelium-derived vasoactive factors and hypertension: possible roles in pathogenesis and as treatment targets","volume":"12","author":"F\u00e9l\u00e9tou","year":"2010","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.ejmech.2025.117724_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.590534","article-title":"Small and intermediate calcium activated potassium channels in the heart: Role and strategies in the treatment of cardiovascular diseases","volume":"11","author":"Weisbrod","year":"2020","journal-title":"Front. Physiol."},{"issue":"2","key":"10.1016\/j.ejmech.2025.117724_bib35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1517\/14728220903540257","article-title":"Vascular KCa-channels as therapeutic targets in hypertension and restenosis disease","volume":"14","author":"K\u00f6hler","year":"2010","journal-title":"Expert Opin. Ther. Targets"},{"issue":"11","key":"10.1016\/j.ejmech.2025.117724_bib36","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.15252\/emmm.201707725","article-title":"Treatment of hypertension by increasing impaired endothelial TRPV4-KCa2.3 interaction","volume":"9","author":"He","year":"2017","journal-title":"EMBO Mol. Med."},{"issue":"333","key":"10.1016\/j.ejmech.2025.117724_bib37","doi-asserted-by":"crossref","first-page":"ra66","DOI":"10.1126\/scisignal.2005052","article-title":"AKAP150-dependent cooperative TRPV4 channel gating is central to endothelium-dependent vasodilation and is disrupted in hypertension","volume":"7","author":"Sonkusare","year":"2014","journal-title":"Sci. Signal."},{"issue":"10","key":"10.1016\/j.ejmech.2025.117724_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/antiox13101158","article-title":"Signaling paradigms of H(2)S-Induced vasodilation: a comprehensive review","volume":"13","author":"Munteanu","year":"2024","journal-title":"Antioxidants"},{"issue":"4","key":"10.1016\/j.ejmech.2025.117724_bib39","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1476-5381.2009.00132.x","article-title":"Endothelial ca+-Activated K+ channels in normal and impaired EDHF-Dilator responses--relevance to cardiovascular pathologies and drug discovery","volume":"157","author":"Grgic","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.ejmech.2025.117724_bib40","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1161\/01.RES.0000196741.99904.e4","article-title":"EDHF redux: eets, TRPV4, and Ca2+ Sparks","volume":"97","author":"Kotlikoff","year":"2005","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.ejmech.2025.117724_bib41","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1161\/HYPERTENSIONAHA.116.07110","article-title":"Downregulation of endothelial transient receptor potential vanilloid type 4 channel and small-conductance of Ca2+-Activated K+ channels underpins impaired endothelium-dependent hyperpolarization in hypertension","volume":"69","author":"Seki","year":"2017","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.ejmech.2025.117724_bib42","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1161\/01.ATV.0000217611.81085.c5","article-title":"Endothelium-derived hyperpolarizing factor: where are we now?","volume":"26","author":"F\u00e9l\u00e9tou","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.ejmech.2025.117724_bib43","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1124\/jpet.121.001034","article-title":"High salt upregulates Ca(2+)-Sensing receptor expression and Ca(2+)-Induced relaxation of contracted mesenteric arteries from dahl salt-sensitive rats","volume":"381","author":"Bridges","year":"2022","journal-title":"J Pharmacol Exp Ther"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425004891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425004891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T05:12:23Z","timestamp":1765602743000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425004891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":43,"alternative-id":["S0223523425004891"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117724","relation":{},"ISSN":["0223-5234"],"issn-type":[{"type":"print","value":"0223-5234"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and biological evaluation of TRPV4-KCa2.3 coupling enhancers as novel therapeutic agents for hypertension","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.117724","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117724"}}